시장보고서
상품코드
1986310

병원용 로봇 지원 수술 시장 : 시장 규모, 점유율, 동향 분석(용도별, 수술 유형별, 수술 복잡도별, 지역별), 부문별 예측(2026-2033년)

Hospital Assisted Surgical Robot Procedures Market Size, Share & Trends Analysis Report By Application, By Procedure Type, By Procedure Complexity, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 8,854,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,342,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,319,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

병원용 로봇 지원 수술 시장 요약

세계의 병원용 로봇 지원 수술 시장 규모는 2025년에 110억 7,000만 달러로 추정되었으며, 2033년까지 394억 2,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 연평균 복합 성장률(CAGR) 17.3%를 나타낼 것으로 예측됩니다. 이 시장은 회복 기간 단축, 합병증 감소, 정확도 향상을 가져오는 최소침습 수술에 대한 수요에 힘입어 성장하고 있습니다.

첨단 로봇 기술의 도입, 의료 인프라에 대한 투자 확대, 복잡한 수술 질환 증가는 수술용 로봇의 사용 확대를 촉진하고 있습니다. 2025년 1월, 미국 워렌 메모리얼 병원은 다빈치 Xi 시스템을 이용한 로봇 보조 일반외과 수술을 시작했습니다. 이를 통해 정확도 향상, 조직 손상 감소, 환자 회복 기간 단축을 실현한 최소 침습적 복부 수술이 가능해졌습니다.

이 시장은 정확도 향상, 수술 후 합병증 감소, 환자의 회복 기간 단축을 가져오는 최소 침습 수술에 대한 수요 증가에 의해 주도되고 있습니다. 로봇 시스템을 통해 외과의사는 복잡한 수술을 보다 정확하고 일관성 있게 수행할 수 있고, 임상 결과와 업무 효율성을 향상시킬 수 있기 때문에 병원은 이러한 기술을 도입하도록 장려하고 있습니다. 2025년 11월, 미국 오레인 종합병원은 2026년 초에 da Vinci Xi 시스템을 이용한 로봇 수술 프로그램을 시작할 계획을 발표했습니다. 이 기술을 통해 외과의사는 정밀한 수술을 할 수 있고, 환자는 더 빠른 회복, 통증 감소 및 치료 결과를 개선할 수 있습니다.

인공지능, 고화질 영상, 다관절 로봇 시스템의 통합을 통해 의료 서비스 제공업체는 특히 3차 의료기관과 전문 병원에서 수술 능력을 확장하고 워크플로우를 최적화하며 더 나은 품질의 수술 치료를 제공할 수 있습니다. 2026년 2월, 노바스코샤 보건부 산하 QEII 건강과학센터는 278만 달러의 기부금으로 다빈치 Xi 로봇을 도입하여 노바스코샤 주 최초의 로봇 지원 대장, 흉부, 간 담도 수술을 실현했습니다. 이 시스템은 이미 56건의 수술을 지원했으며, 여러 전문 분야에 걸쳐 첨단 의료에 대한 접근성을 확대되고 있습니다.

로봇 보조 수술에 대한 교육을 받은 숙련된 외과의사의 확보가 증가하고 있으며, 로봇 수술의 장점에 대한 환자들의 인식이 높아짐과 더불어 유리한 보상 체계가 시장 성장의 원동력이 되고 있습니다. 2026년 2월, NHS East of England는 '국가 암 계획'을 발표했습니다. 이 계획은 2035년까지 로봇 보조 수술을 7만 건에서 50만 건으로 확대하고, 신속한 진단, 전문의 주도 치료, 유전체 검사를 통해 암 의료를 개선하는 것을 목표로 하고 있습니다. 이 계획에는 당일 로봇 보조 전립선 전절제술과 250건 이상의 최소침습 흉부 수술이 포함되어 있으며, 이를 통해 지역 내 환자들의 입원 기간을 단축하고 회복을 촉진할 수 있을 것으로 기대됩니다.

자주 묻는 질문

  • 병원용 로봇 지원 수술 시장 규모는 어떻게 예측되나요?
  • 로봇 보조 수술의 장점은 무엇인가요?
  • 최소침습 수술에 대한 수요는 어떤 요인에 의해 증가하고 있나요?
  • 로봇 수술 프로그램을 도입한 병원은 어디인가요?
  • 로봇 수술의 교육을 받은 외과의사 확보는 어떤 영향을 미치고 있나요?
  • NHS East of England의 '국가 암 계획'의 목표는 무엇인가요?

목차

제1장 분석 방법과 범위

제2장 주요 요약

제3장 세계의 병원용 로봇 지원 수술 시장 : 변동 요인, 동향 및 범위

제4장 세계의 병원용 로봇 지원 수술 시장 : 용도별 분석(단위 : 100만 달러, 2021년-2033년)

제5장 세계의 병원용 로봇 지원 수술 시장 : 수술 유형별 분석(단위 : 100만 달러, 2021년-2033년)

제6장 세계의 병원용 로봇 지원 수술 시장 : 수술 복잡도 별 분석(단위 : 100만 달러, 2021년-2033년)

제7장 세계의 병원용 로봇 지원 수술 시장 : 지역별 분석(2021년-2033년)

제8장 경쟁 구도

LSH 26.05.04

Hospital Assisted Surgical Robot Procedures Market Summary

The global hospital assisted surgical robot procedures market size was estimated at USD 11.07 billion in 2025 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 17.3% from 2026 to 2033. The market is driven by the demand for minimally invasive surgeries, which reduce recovery time and complications while improving precision.

Adoption of advanced robotic technologies, rising investments in healthcare infrastructure, and the prevalence of complex surgical conditions are expanding the use of surgical robots. In January 2025, Warren Memorial Hospital in the U.S. began performing robotic-assisted general surgery using the da Vinci Xi system, enabling minimally invasive abdominal procedures with improved precision, reduced tissue damage, and faster patient recovery.

The market is driven by the rising demand for minimally invasive surgeries, which offer enhanced precision, reduced post-operative complications, and shorter patient recovery times. Robotic systems enable surgeons to perform complex procedures with greater accuracy and consistency, improving clinical outcomes and operational efficiency, thereby encouraging hospitals to integrate these technologies.In November 2025, Olean General Hospital in the U.S. announced plans to launch a robotic surgery program with the da Vinci Xi system in early 2026. The technology enables surgeons to perform procedures with precision, offering patients quicker recovery, less pain, and improved outcomes.

Integration of artificial intelligence, high-definition imaging, and multi-armed robotic systems allows healthcare providers to expand procedural capabilities, optimize workflow, and deliver higher-quality surgical care, particularly in tertiary and specialty hospitals. In February 2026, Nova Scotia Health's QEII Health Sciences Centre introduced the da Vinci Xi robot with a USD 2.78 million donor contribution, enabling the province's first robot-assisted colorectal, thoracic, and hepatobiliary surgeries. The system has already supported 56 procedures and expanded access to advanced care across multiple specialties.

Market growth is also propelled by the increasing availability of a skilled surgical workforce trained in robotic-assisted procedures, alongside favorable reimbursement frameworks and growing patient awareness of the benefits of robotic surgery. In February 2026, NHS East of England unveiled its National Cancer Plan, aiming to expand robot-assisted surgeries from 70,000 to 500,000 procedures by 2035 and to improve cancer care through faster diagnostics, specialist-centered treatment, and genomic testing. The plan includes same-day robotic prostatectomies and over 250 minimally invasive thoracic procedures, reducing hospital stays and enhancing recovery for patients across the region.

Global Hospital Assisted Surgical Robot Procedures Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global hospital assisted surgical robot procedures market report based on application, procedure type, procedure complexity, and region:

  • Application Outlook (Revenue USD Million, 2021 - 2033)
  • Urology
  • General Surgery
  • Gynecology
  • Orthopedics
  • Cardiothoracic
  • Neurosurgery
  • ENT (Otolaryngology)
  • Bariatric / Metabolic
  • Other specialties
  • Procedure Type Outlook (Revenue USD Million, 2021 - 2033)
  • Minimally-invasive laparoscopic robotic-assisted
  • Endoscopic robotic procedures
  • Open-assisted (hybrid open procedures)
  • Others (Percutaneous / catheter-based robotic, novel)
  • Procedure Complexity Outlook (Revenue USD Million, 2021 - 2033)
  • High complexity (oncologic, cardiac, neuro)
  • Medium complexity (advanced laparoscopy, joint replacements)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Procedure type outlook
    • 2.2.3. Procedure complexity outlook
  • 2.3. Competitive Insights

Chapter 3. Global Hospital Assisted Surgical Robot Procedures Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Hospital Assisted Surgical Robot Procedures: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Hospital Assisted Surgical Robot Procedures Market, by Application, 2021 to 2033
  • 4.5. Urology
    • 4.5.1. Urology market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. General Surgery
    • 4.6.1. General surgery market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Gynecology
    • 4.7.1. Gynecology market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Orthopedics
    • 4.8.1. Orthopedics market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Cardiothoracic
    • 4.9.1. Cardiothoracic market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.10. Neurosurgery
    • 4.10.1. Neurosurgery market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.11. ENT (Otolaryngology)
    • 4.11.1. ENT (Otolaryngology) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.12. Bariatric / Metabolic
    • 4.12.1. Bariatric / metabolic market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Procedure Type Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Hospital Assisted Surgical Robot Procedures Market, by Procedure Type, 2021 to 2033
  • 5.5. Minimally-invasive laparoscopic robotic-assisted
    • 5.5.1. Minimally-invasive laparoscopic robotic-assisted market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Endoscopic robotic procedures
    • 5.6.1. Endoscopic robotic procedures market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Open-assisted (hybrid open procedures)
    • 5.7.1. Open-assisted (hybrid open procedures) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Others (Percutaneous / catheter-based robotic, novel)
    • 5.8.1. Others (Percutaneous / catheter-based robotic, novel) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Procedure Complexity, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Procedure Complexity Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Hospital Assisted Surgical Robot Procedures Market, by Procedure Complexity, 2021 to 2033
  • 6.5. High Complexity
    • 6.5.1. High complexity market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Medium Complexity
    • 6.6.1. Medium complexity market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Hospital Assisted Surgical Robot Procedures Market Share by Region, 2025 & 2033:
  • 7.5. North America
    • 7.5.1. North America hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Japan hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. China hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. India hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Australia hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. South Korea hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Regulatory Scenario
      • 7.7.7.3. Competitive Scenario
      • 7.7.7.4. Thailand hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Brazil hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Scenario
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Argentina hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. South Africa hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. Saudi Arabia hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. UAE hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Regulatory Scenario
      • 7.9.5.3. Competitive Scenario
      • 7.9.5.4. Kuwait hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Intuitive Surgical
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. THINK Surgical, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Smith+Nephew
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Stryker
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Zimmer Biomet
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. CMR Surgical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Asensus Surgical US, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Renishaw PLC.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. MOON Surgical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기